SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), a leading provider and developer of advanced personal telemedicine solutions, today announced that it has signed a distribution agreement for its innovative smartheart™ device with USCI Holdings, Inc., of Japan. USCI shall immediately order a sizable amount of smartheart™ devices already this quarter with a target of buying at least 1,000 smarthearts until the end of 2016.
smartheart™ is the first and only personal mobile 12-lead ECG device on the market that enables the detection of heart attacks. USCI Holdings will target the professional healthcare community, i.e. physicians and general practitioners. With smartheart and a smartphone or tablet they can perform a full hospital grade ECG and receive from SHL's global telemedicine centre an ECG interpretation.
Erez Alroy, Co-CEO of SHL, commented: "We are delighted to have signed this important distribution agreement in Japan with USCI. It is a validation for the unique features of our smartheart™ and allows SHL, with the focus on physicians and the professional market, to build credibility for the smartheart in the Japanese healthcare community."
KFF Health News' 'What the Health?': End-of-year chaos on Capitol Hill